AGF Management’s Analog Devices ADI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108M Buy
273,122
+22,293
+9% +$8.82M 0.42% 70
2026
Q1
$79.8M Sell
250,829
-102,183
-29% -$32.5M 0.36% 89
2025
Q4
$95.7M Sell
353,012
-31,113
-8% -$7.82M 0.42% 68
2025
Q3
$94.4M Sell
384,125
-847
-0.2% -$204K 0.42% 71
2025
Q2
$91.6M Sell
384,972
-216,204
-36% -$45M 0.42% 71
2025
Q1
$121M Buy
601,176
+101,493
+20% +$21.9M 0.64% 48
2024
Q4
$106M Buy
499,683
+68,727
+16% +$15.2M 0.53% 56
2024
Q3
$99.2M Buy
430,956
+77,012
+22% +$17.4M 0.5% 65
2024
Q2
$80.8M Sell
353,944
-41,036
-10% -$8.76M 0.45% 74
2024
Q1
$78.1M Sell
394,980
-72,444
-15% -$13.9M 0.43% 79
2023
Q4
$92.8M Buy
467,424
+85,475
+22% +$15.3M 0.55% 64
2023
Q3
$66.9M Buy
+381,949
New +$70.4M 0.47% 75
2023
Q2
Sell
-318,608
Closed -$62.8M 654
2023
Q1
$62.8M Sell
318,608
-56,345
-15% -$10.1M 0.43% 79
2022
Q4
$61.5M Buy
+374,953
New +$58.5M 0.45% 74

Other funds holding ADI

AGF Management's ADI Position: Q2 2026 in Review

AGF Management increased its Analog Devices (ADI) stake by 8.9% in Q2 2026, buying an estimated $8.82M and bringing the position to 273,122 shares worth $108M. The position accounts for 0.42% of the portfolio, ranked #70.

AGF Management first reported a position in ADI in Q4 2022 and has held it in 14 quarters since. The position peaked at $121M in Q1 2025. 2,263 funds tracked by Wall St. Rank hold ADI as of Q2 2026.

  • AGF Management held 273,122 shares of Analog Devices worth $108M as of Q2 2026.
  • AGF Management bought 22,293 Analog Devices shares in Q2 2026, an estimated $8.82M.
  • Analog Devices made up 0.42% of AGF Management's portfolio in Q2 2026, its #70 holding.
  • AGF Management first reported a position in Analog Devices in Q4 2022 and has held it in 14 quarters since.
  • AGF Management's Analog Devices position peaked at $121M in Q1 2025.
  • 2,263 funds tracked by Wall St. Rank held Analog Devices as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.